3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with Neoplasm Metastasis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bida, B; Henker, C; Markwardt, J; Schlag, P | 1 |
1 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Neoplasm Metastasis
Article | Year |
---|---|
[Diagnostic value of 123iodine-ibzm scintigraphy for staging of malignant melanomas].
Topics: Benzamides; Brain Neoplasms; Dopamine Antagonists; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Magnetic Resonance Imaging; Melanoma; Neoplasm Metastasis; Neoplasm Staging; Pyrrolidines; Radionuclide Imaging; Skin Neoplasms; Tomography, X-Ray Computed | 1997 |